Novartis is structured to deliver innovative products, exploit global scale, and respond to new opportunities and risks. Our divisions - Innovative Medicines and Sandoz - are supported by functional organizations with global scale.
Innovative Medicines
Made up of two business units, Novartis Pharmaceuticals which includes Novartis Gene Therapies, and Novartis Oncology & our Innovative Medicines Division commercializes innovative patented medicines to enhance health outcomes for patients and healthcare professionals.
Sandoz
Sandoz is a global leader in generic pharmaceuticals and biosimilars that pioneers novel approaches to help people around the world access high-quality medicines.
1859
Served areaWorldwide
Headcount110,000
HeadquartersLichtstrasse 35, 4002 Basel – Switzerland
2,204,239,028
IPONov. 18, 1991
Stock exchange(s)SIX Swiss Exchange